(Q42271409)

English

Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus

scientific article published on 6 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Epstein–Barr virus

1 reference

based on heuristic

inferred from title

Alexandre Naime Barbosa

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Suzane Ramos da Silva

object named as

Suzane Ramos da Silva

2

0 references

Deilson Elgui de Oliveira

object named as

Deilson Elgui de Oliveira

6

0 references

author name string

Leila Bertoni Giron

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Ricardo Augusto Monteiro de Barros Almeida

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Lenice do Rosário de Souza

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

6 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

85

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

2110-2118

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

The genome of Epstein-Barr virus type 2 strain AG876.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

LMP1 structure and signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

HIV infection and lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Human Endogenous Retrovirus (HERV)-R family in primates: Chromosomal location, gene expression, and evolution

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein-Barr viraemia.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Concurrent CMV and EBV DNAemia is significantly correlated with a delay in the response to HAART in treatment-naive HIV type 1-positive patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Detection of herpesvirus DNA in cerebrospinal fluid and correlation with clinical symptoms.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

AIDS and cancer in the era of highly active antiretroviral therapy (HAART).

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Epstein-Barr virus infection in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Epstein-Barr virus and cancer

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

EBV the prototypical human tumor virus--just how bad is it?

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Tissue distribution of Epstein-Barr virus genotypes in hosts coinfected by HIV.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

The incidence of lymphoma in the UK haemophilia population between 1978 and 1999.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

AIDS and associated malignancies

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Epstein-Barr virus: 40 years on

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

The expression and function of Epstein-Barr virus encoded latent genes

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

A quantification of human cells using an ERV-3 real time PCR assay

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23722

21 January 2018

Identifiers

10.1002/JMV.23722

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

release_swj7mrxg6rhnfdjcocgzafg6sa

1 reference

https://api.fatcat.wiki/v0/release/swj7mrxg6rhnfdjcocgzafg6sa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42271409&oldid=1940770207"